Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sergey I. Poluektov"'
Autor:
Marina D. Budurova, Vladimir S. Trifanov, Vladimir A. Bagrov, Mikhail V. Lozhkin, Maria A. Chernichenko, Victoria S. Surkova, Sergey I. Poluektov, Liudmila N. Lyubchenko
Publikováno v:
Современная онкология, Vol 25, Iss 4, Pp 540-546 (2023)
Inflammatory myofibroblastic tumors (IMTs) are extremely rare neoplasms, accounting for 0.04–0.7% of all tumors. Data on their clinical presentation, pathogenesis, and biological behavior are scarce. They can occur at any age, involving equally mal
Externí odkaz:
https://doaj.org/article/df8b92e5fb9445b1acf2faa00ed75405
Autor:
Marina D. Budurova, Vladimir S. Trifanov, Vladimir V. Kopylov, Olga S. Kuznetsova, Maria A. Chernichenko, Sergey I. Poluektov
Publikováno v:
Современная онкология, Vol 25, Iss 3, Pp 401-405 (2023)
Colorectal cancer (CRC) is one of the most common oncological diseases. On average, in 20–25% of cases after radical surgical treatment of CRC, the progression of the disease in the form of metachronous metastases in the liver and lungs, as the mos
Externí odkaz:
https://doaj.org/article/2833dfe1b34449a2861daf468408ebba
Autor:
Oksana V. Katelnitskaya, Sergey I. Poluektov, Oleg Yu. Kaymakchi, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Andrey V. Dashkov, Aleksandr V. Snezhko, Oleg I. Kit, Elena M. Frantsiyants, Roman E. Tolmakh, Vladislav K. Pavlov, Dmitry O. Kaymakchi, Natalya V. Soldatkina, Maksim A. Vereshchak, Maksim K. Aleksandrovich, Yuriy A. Gevorkyan
Publikováno v:
Journal of Clinical Oncology. 39:e16220-e16220
e16220 Background: Patients with pancreatic cancer are at high risk for venous thrombosis. Thrombotic episodes are most often recorded at the tumor diagnosis, surgical treatment and chemotherapy courses, or the disease recurrence. This complication p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::448b0d42a610d728af31f739e2be8c73
https://doi.org/10.1200/jco.2021.39.15_suppl.e16220
https://doi.org/10.1200/jco.2021.39.15_suppl.e16220
Relationship between circulating tumor cells and ZEB1 expression in tumor cells in colorectal cancer
Autor:
Maksim K. Aleksandrovich, Oksana G. Shulgina, Elena Yu. Zlatnik, Elena P. Ulianova, Oleg I. Kit, Ellada A. Mirzoyan, Anastasia O. Sitkovskaya, Inna Arnoldovna Novikova, Maksim A. Vereshchak, Andrey V. Dashkov, Elena A. Dzhenkova, Natalya V. Soldatkina, Sergey I. Poluektov, Vladimir E. Kolesnikov, Vladislav K. Pavlov, Yuriy A. Gevorkyan, Aleksandr B. Sagakyants, Dmitry O. Kaymakchi, Oksana V. Katelnitskaya, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 39:e15509-e15509
e15509 Background: Intravasation and circulation of tumor cells involves active invasion of cells with an enhanced migration potential as a result of the epithelial-mesenchymal transition (EMT). The ZEB1 protein is one of the key regulators of this p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2260aaa3301a3063ed37d8ed3bd2363
https://doi.org/10.1200/jco.2021.39.15_suppl.e15509
https://doi.org/10.1200/jco.2021.39.15_suppl.e15509
Autor:
Sergey I. Poluektov, Elena P. Ulianova, Natalya V. Soldatkina, Oleg I. Kit, Dmitriy A. Savchenko, Andrey V. Dashkov, Vladislav K. Pavlov, Oksana V. Katelnitskaya, Ellada A. Mirzoyan, Vladimir E. Kolesnikov, Anastasia O. Sitkovskaya, Maksim A. Vereshchak, Maksim K. Aleksandrovich, Roman E. Tolmakh, Inna Arnoldovna Novikova, Elena A. Dzhenkova, Elena Yu. Zlatnik, Oksana G. Shulgina, Yuriy A. Gevorkyan, Dmitry O. Kaymakchi
Publikováno v:
Journal of Clinical Oncology. 39:3522-3522
3522 Background: Cancer stem cells (CSCs) capable of self-sustaining and multipotent differentiation are considered among the most important factors limiting treatment effectiveness. ALDH1 is a marker of colorectal cancer (CRC) CSCs; it is involved i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae7069835fdf5ae45ff9cb93ededfc0a
https://doi.org/10.1200/jco.2021.39.15_suppl.3522
https://doi.org/10.1200/jco.2021.39.15_suppl.3522
Autor:
Elena Yu. Zlatnik, Vladislav K. Pavlov, Oleg I. Kit, Maksim K. Aleksandrovich, Yuriy A. Gevorkyan, Ellada A. Mirzoyan, Inna Arnoldovna Novikova, Oksana V. Katelnitskaya, Dmitriy A. Savchenko, Anastasia O. Sitkovskaya, Andrey V. Dashkov, Sergey I. Poluektov, Natalya V. Soldatkina, Maksim A. Vereshchak, Roman E. Tolmakh, Dmitry O. Kaymakchi, Elena S. Bondarenko, Vladimir E. Kolesnikov
Publikováno v:
Journal of Clinical Oncology. 39:e15508-e15508
e15508 Background: The most important stages of metastatic cascade are extravasation and invasion of malignant cells and their surviving in blood. The vast majority of circulating tumor cells (CTC) is destroyed by immune cells. The role of immune sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::601bbd9e61defe0604d4b0b6bac7c108
https://doi.org/10.1200/jco.2021.39.15_suppl.e15508
https://doi.org/10.1200/jco.2021.39.15_suppl.e15508
Autor:
Dmitriy A. Savchenko, Sergey I. Poluektov, Andrey V. Dashkov, Maksim K. Aleksandrovich, Oksana V. Katelnitskaya, Aleksandr V. Snezhko, Dmitry O. Kaymakchi, Oleg I. Kit, Vladislav K. Pavlov, Natalya V. Soldatkina, Oleg Yu. Kaymakchi, Maksim A. Vereshchak, Evgeniy N. Kolesnikov, Yuriy A. Gevorkyan, Roman E. Tolmakh, Vladimir E. Kolesnikov
Publikováno v:
Journal of Clinical Oncology. 39:e16221-e16221
e16221 Background: Restoration the hepatic arterial blood flow is required in traumatic or iatrogenic damage to the hepatic artery and its branches, as well as in the planned resection of the hepatic artery with subsequent reconstruction. Various way
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75c95b4ab4574bb1079e6e462797c11e
https://doi.org/10.1200/jco.2021.39.15_suppl.e16221
https://doi.org/10.1200/jco.2021.39.15_suppl.e16221
Autor:
Aleksandr V. Shaposhnikov, Sergey I. Poluektov, Ellada A. Mirzoyan, Anastasia O. Sitkovskaya, Maksim K. Aleksandrovich, Vladimir E. Kolesnikov, Oksana G. Shulgina, Oksana V. Katelnitskaya, Elena A. Dzhenkova, Natalya V. Soldatkina, Vladislav K. Pavlov, Dmitry O. Kaymakchi, Maksim A. Vereshchak, Elena P. Ulianova, Yuriy A. Gevorkyan, Oleg I. Kit, Elena Yu. Zlatnik, Inna Arnoldovna Novikova, Dmitriy A. Savchenko, Andrey V. Dashkov
Publikováno v:
Journal of Clinical Oncology. 39:e15510-e15510
e15510 Background: Tumor is a structure where malignant cells interact, among others, with cells of the adaptive and innate immune systems largely determining the tumor microenvironment. The role of TILs in the disease prognosis has been shown. The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4ff86a3e1131481d4cb232d6d3633be
https://doi.org/10.1200/jco.2021.39.15_suppl.e15510
https://doi.org/10.1200/jco.2021.39.15_suppl.e15510
Autor:
Vladimir A. Dontsov, Inna Arnoldovna Novikova, Denis S. Kutilin, Andrey V. Dashkov, Natalya N. Timoshkina, Evgeniy N. Kolesnikov, Dmitry S. Petrov, Roman E. Tolmakh, Dmitry Haragezov, Natalya V. Soldatkina, Sergey I. Poluektov, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 38:e13518-e13518
e13518 Background: With the advent of deep sequencing, enormous variability in miRNA biogenesis was detected, which means that many different sequences can potentially be generated from the same miRNA precursor, potentially having different targets a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a81ed6e8c85e034e3a0570582d942a55
https://doi.org/10.1200/jco.2020.38.15_suppl.e13518
https://doi.org/10.1200/jco.2020.38.15_suppl.e13518
Autor:
Dmitry S. Petrov, Sergei A. Ilchenko, Dmitry O. Kaymakchi, Fedor N. Grechkin, Roman E. Tolmakh, Ellada A. Mirzoyan, Dmitry A. Kharagezov, Yuriy A. Gevorkyan, Vladimir A. Dontsov, Natalya V. Soldatkina, Denis S. Kutilin, Andrey V. Dashkov, Nairi B. Oganyan, Oleg N. Stateshny, Vladimir E. Kolesnikov, Yuriy A. Fomenko, Sergey I. Poluektov, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 38:e16104-e16104
e16104 Background: Cancer-testis antigens (CTAs) can be used for immunotherapeutic approaches and early detection of malignant tumors. Despite numerous studies of CTA expression in various tumors, including colon tumors, the mechanisms of transcripti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::159566082f419c6df5b44a8445ac73e6
https://doi.org/10.1200/jco.2020.38.15_suppl.e16104
https://doi.org/10.1200/jco.2020.38.15_suppl.e16104